BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that Howard Weisman, EKR’s President and CEO, will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18 at 8:30 a.m. ET. The conference will be held from November 17 - 18, 2009 at the St. Regis Hotel, 2 East 55th Street, New York, NY.
